Farmacología y Toxicología
Departamento
Hospital San Pedro
Logroño, EspañaPublicaciones en colaboración con investigadores/as de Hospital San Pedro (4)
2017
-
Simplification to dual therapy (atazanavir/ritonavir1lamivudine) versus standard triple therapy [atazanavir/ritonavir1two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study)
Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 1, pp. 246-253
2016
-
Residual neuromuscular blockade in the postanesthesia care unit: Observational cross-sectional study of a multicenter cohort
Minerva Anestesiologica, Vol. 82, Núm. 12, pp. 1267-1277
2015
-
Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial
The Lancet Infectious Diseases, Vol. 15, Núm. 7, pp. 775-784
2014
-
Selected CD133+ progenitor cells to promote angiogenesis in patients with refractory angina final results of the PROGENITOR randomized trial
Circulation Research, Vol. 115, Núm. 11, pp. 950-960